Cardio Oncology

FCACC-FLASCO  CARDIO-ONCOLOGY COLLABORATIVE

Through a grant funded by the ACC Board of Governors, the Florida Chapter, American College of Cardiology and the Florida Society of Clinical Oncology developed a joint program to assess gaps in knowledge and then create educational materials about the emerging field of cardio-oncology. The results of the work of the joint group are a series of educational materials aimed to close the knowledge gaps.

COLLABORATION among health care providers is becoming increasingly important. To assess the gaps in knowledge of Cardio- Oncology, the Florida chapters of the ACC and ASCO have partnered to create joint educational materials.

DECIDING who needs a Cardio-Oncology consult is still a moving target and we hope to be able to increase awareness of cardio-toxicities and bridge the gap to make sure patients are cared for in a streamlined, efficient fashion.

IN THE FUTURE, we encourage participation of others as this field continues to grow, and hope you get involved with FCACC and FLASCO Cardio-Oncology sections as well as the National sections.

SURVEY RESULTS

Thank you to FCACC members who took the cardio-oncology survey. A few advanced highlights of the results are below.

• 50%  said there are no Cardio Oncology Services in their community, 42 % said yes, 8 % didn’t even know.
• From those who said yes (they have CO services in their community), 66 % have not referred any patients to them.
• 90% said CO services are of value to their communities

5-FU and Capecitabine  Diego Sadler, MD, FACC	Anthracycline Cardio-Toxicity: The Calm Before the Storm Anita M. Arnold, DO, FACC, MBA
Arrhythmias and QT Prolongationin Cancer Patients Michael Fradley, MD, FACC	Cardiac Imaging for Early Detection of Cancer Therapeutics-Related Cardiac Dysfunction Patricia Guerrero, MD, FACC
Immune Check Point Inhibitors Diego Sadler, MD, FACC	Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: ASCO Clinical Practice Guidelines. Taken from: Journal of Clinical Oncology 2017 35:8, 893-911  Compiled by Deepti Bhandare, MD, FACC
Proteasome Inhibitors  Patricia Guerrero, MD, FACC	Radiation toxicity  Michael Fradley, MD
Trastuzumab Roohi Ismail-Khan, MD	Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer Karla Quevedo, MD, FACC

New article in cardio oncology journal on results from international covid-19 survey

Click here to read the article.

JACC: Cardio Oncology

Florida Inter-Specialty Collaborative Project to Improve Cardio-Oncology Awareness and Identify Existing Knowledge Gaps

Cardio Oncology Journal

Practical and Cost Effective Model to Build and Sustain a Cardio-Oncology Program

European Heart Journal

Checkpoint Inhibitor-induced Myocarditis and Myasthenia Gravis in a Recurrent Metastatic Thymic Carcinoma Patient